Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.

The citrus bioflavonoids market is projected to grow from $1.08 billion in 2023 to $1.2 billion in 2024, at a CAGR of 10.6%. Increased consumer interest in natural health products, the expanding use ...

Kardashian Barker discusses the brand’s latest hair growth and anti-shedding capsule launch, her current post-pregnancy hair ...

KOURTNEY Kardashian is facing backlash after being branded “shameless” over an ill-timed birthday post on Kris Jenner’s birthday. Reality star Kourtney, 45, came under fire for ...

Concerns over delayed stomach emptying and possible aspiration risk had some doctors thinking that people taking GLP-1 meds should discontinue the meds before a surgery However, stopping the drugs ...

Glucagon-like peptide-1 (GLP-1) drugs can help you lose weight and manage type 2 diabetes. Whether you buy these medications online or in person, it is important to get a prescription from ...

HealthDay News — Among privately insured patients, there was a doubling in the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as antiobesity treatment from 2022 to 2023 ...

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day. Subscribe for FREE GLP-1s, used to treat obesity, diabetes and heart problems, ...

Concerns over delayed stomach emptying and possible aspiration risk had some doctors thinking that people taking GLP-1 meds should discontinue the meds before a surgery However, stopping the drugs ...

Dallas-based Smoothie King debuted its GLP-1 Support Menu on Tuesday for those who are using GLP-1 agonists to help them achieve their weight-loss goals. Five new high protein smoothies come with 20 ...

Results from the trial included a 140% average increase in GLP-1 levels in the body leading to an average weight loss of 9 pounds in 8 weeks and up to 25 pounds in 12 weeks in participants.

LifeVantage (LFVN) announced results from a human clinical trial performed on the new MindBody GLP-1 System. Results from the trial included a 140% average increase in GLP-1 levels in the body ...